Frontier Bio
PrivateLast Round
Strategic
Aug 29, 2025
Total Funding Raised
$356,000
Momentum Score
25 /100
Company Overview
Frontier Bio is a biotechnology company that develops lab-grown human tissues to provide an alternative to animal testing and ultimately address the organ transplant shortage. Using proprietary 3D bioprinting, stem cell technology, and self-assembly techniques, the company engineers tissues such as blood vessels, lung microtissues, and neural microtissues. These products are used for medical device testing, drug development, disease modeling, and surgical training. Founded in 2018 and based in Hayward, California, Frontier Bio collaborates with institutions like the Mayo Clinic and is funded by organizations including the National Science Foundation and Alchemist Accelerator. The company's long-term vision is to create on-demand, implantable organs, starting with tissue-engineered blood vessels.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontier Bio Comps
Public and private peers based on sector, stage, and business model.
Frontier Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 29, 2025 | ||||
| Grant | Aug 15, 2021 | ||||
| Seed | May 14, 2020 | ||||
| Seed | May 2, 2019 |
Key People
Founding team and executive leadership
Frontier Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed |
| Brinc | Seed |
| Boutique Venture Partners | Strategic |
| Break Off Capital | Strategic |
| Alchemist Accelerator | Seed, Strategic |
| Immortal Dragons | Strategic |
| Mistletoe | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Won 'Best Paper' award at the 50th Annual VESS meeting.
- Apr 9, 2026
Received Best Paper Award at the VESS Annual Meeting.
Frontier Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Frontier Bio's valuation, stock price, and market status.
